WHO tips need manufacturers to apply a ongoing chance management process for sterility test isolators, which include typical threat assessments and the event of danger-centered Handle techniques. Manufacturers seeking to carry out these methods should deliver robust validation data to display their equivalence to pharmacopoeial solutions.